Compare Inovio Pharmaceuticals Inc (INO) vs Marriott International Inc (MAR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Inovio Pharmaceuticals Inc vs Marriott International Inc — how do they compare? Inovio Pharmaceuticals Inc trades at $1.08 (market cap $89.27M), while Marriott International Inc trades at $366.91 (market cap $96.76B). The key difference: Marriott International Inc is far larger — about 1083.9× Inovio Pharmaceuticals Inc's market cap, and Marriott International Inc pays a 0.8% dividend while Inovio Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| INO | MAR | |
|---|---|---|
Market Cap | $89.27M | $96.76B |
Sector | Health | Consumer Cyclical |
52-Week High | $2.87 | $402.54 |
52-Week Low | $1.05 | $255.35 |
Enterprise Value | $60.28M | $113.71B |
Dividend Yield | — | 0.8% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Inovio Pharmaceuticals Inc
Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
Read more on INO →About Marriott International Inc
Marriott International Inc. of Maryland is a worldwide operator and franchisor of hotels. The Company franchises lodging facilities and vacation timesharing resorts under various brand names. Marriott also provides services to home and condominium owner associations for projects associated with several of its brands.
Read more on MAR →
